文章名稱引用次數(shù)

• Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)80
• Conjunctivitis in dupilumab clinical trials61
• Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis54
• Deep-learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumour diagnosis47
• Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa34
• Efficacy and safety of topical JTE- a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study26
• Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement25
• Efficacy and adverse events of oral isotretinoin for acne: a systematic review25
• Alopecia areata: a review of disease pathogenesis25
• A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process25